Belanoff Joseph K's Form 4 filing
Corcept Therapeutics Inc (CORT) · filed Jun 4, 2025
- Accession no.
- 0000950170-25-081939
- Filed
- Jun 4, 2025
- Trade date
- Jun 2, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions. Open-market sales total $3.31M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Belanoff Joseph KCIK 0001286199 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2025 | Common Stock | SSaleDisposed | −4,881 | $78.42F2 | −$382,768.02 | 2,937,104 | Indirect | |
| Jun 2, 2025 | Common Stock | SSaleDisposed | −3,050 | $79.48F4 | −$242,414 | 2,934,054 | Indirect | |
| Jun 2, 2025 | Common Stock | SSaleDisposed | −2,988 | $80.30F5 | −$239,936.4 | 2,931,066 | Indirect | |
| Jun 2, 2025 | Common Stock | SSaleDisposed | −1,820 | $81.33F6 | −$148,020.6 | 2,929,246 | Indirect | |
| Jun 2, 2025 | Common Stock | SSaleDisposed | −1,263 | $82.26F7 | −$103,894.38 | 2,927,983 | Indirect | |
| Jun 2, 2025 | Common Stock | SSaleDisposed | −4,631 | $83.46F8 | −$386,503.26 | 2,923,352 | Indirect | |
| Jun 2, 2025 | Common Stock | SSaleDisposed | −12,959 | $84.57F9 | −$1,095,942.63 | 2,910,393 | Indirect | |
| Jun 2, 2025 | Common Stock | SSaleDisposed | −8,408 | $85.01F10 | −$714,764.08 | 2,901,985 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $77.84 to $78.83 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $78.88 to $79.865 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $79.90 to $80.8925 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $80.92 to $81.78 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F7
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $81.935 to $82.80 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F8
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $82.96 to $83.95 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F9
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $83.975 to $84.94 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F10
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $85.00 to $85.31 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
Remarks
The power of attorney under which this form was signed is on file with the Commission.